TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Gilead Sciences Norway AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
183,152
|
111,731
|
102,730 |
Financial expenses |
13
|
98
|
194 |
Earnings before taxes |
6,899
|
3,852
|
3,405 |
Total assets |
128,889
|
107,870
|
98,347 |
Current assets |
128,171
|
107,870
|
98,347 |
Current liabilities |
50,190
|
29,640
|
25,336 |
Equity capital |
78,699
|
78,230
|
73,011 |
- share capital |
99
|
106
|
103 |
Employees (average) | 6 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
61.1%
|
72.5%
|
74.2% |
Turnover per employee | 17,122 | ||
Profit as a percentage of turnover |
3.8%
|
3.4%
|
3.3% |
Return on assets (ROA) |
5.4%
|
3.7%
![]() |
3.7% |
Current ratio |
255.4%
|
363.9%
|
388.2% |
Return on equity (ROE) |
8.8%
|
4.9%
|
4.7% |
Change turnover |
78,824
|
5,818
|
-47,803 |
Change turnover % |
76%
|
5%
|
-32% |
Chg. No. of employees | 0 | ||
Chg. No. of employees % | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.